Prokidney (PROK) Non-cash Items (2022 - 2026)
Prokidney (PROK) reported Non-cash Items of $42.2 million for Q1 2026, up 4280.29% year-over-year from $963750.0 in Q1 2025, and up 2568.46% on a QoQ basis from $1.6 million in Q4 2025.
Prokidney (PROK) has 5 years of Non-cash Items data on file, last reported at $42.2 million in Q1 2026.
- Quarterly Non-cash Items rose 4280.29% year-over-year to $42.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.2 million (up 4280.29% YoY) and the FY2025 annual result came in at $1.6 million, down 71.27% from the prior year.
- Non-cash Items improved to $42.2 million in Q1 2026 per PROK's latest filing, from $1.6 million in the prior quarter.
- Across five years, Non-cash Items topped out at $42.2 million in Q1 2026 and bottomed at $209000.0 in Q3 2023.
- The 5-year median for Non-cash Items is $2.2 million (2024), against an average of $7.0 million.
- The widest annual swing landed in 2024, when Non-cash Items sank 89.41%; it then jumped 4280.29% in 2026.
- Tracing PROK's Non-cash Items over 5 years: stood at $7.0 million in 2022, then surged by 197.09% to $20.7 million in 2023, then slumped by 89.41% to $2.2 million in 2024, then dropped by 27.99% to $1.6 million in 2025, then surged by 2568.46% to $42.2 million in 2026.
- Per Business Quant, the three latest PROK Non-cash Items figures stand at $42.2 million (Q1 2026), $1.6 million (Q4 2025), and $10.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Prokidney | 259.72 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.22 Mn |
| Mar 31, 2026 | 42.22 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 893,750.00 |
| Sep 30, 2025 | 893,750.00 |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 209,000.00 |
| Sep 30, 2023 | 209,000.00 |
| Jun 30, 2023 | 3.13 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 592,160.00 |
| Mar 31, 2023 | 592,160.00 |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |